ATXI [NASD]
Avenue Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.27 Insider Own53.54% Shs Outstand1.46M Perf Week9.15%
Market Cap7.60M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.71M Perf Month-18.52%
Income-5.20M PEG- EPS next Q- Inst Own3.10% Short Float3.82% Perf Quarter-2.91%
Sales- P/S- EPS this Y29.70% Inst Trans-84.64% Short Ratio0.11 Perf Half Y-61.82%
Book/sh0.41 P/B8.59 EPS next Y- ROA-275.90% Target Price- Perf Year-85.15%
Cash/sh0.42 P/C8.45 EPS next 5Y- ROE-415.90% 52W Range3.00 - 27.75 Perf YTD-74.16%
Dividend- P/FCF- EPS past 5Y10.40% ROI- 52W High-64.86% Beta0.60
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin- 52W Low225.00% ATR1.24
Employees4 Current Ratio2.50 Sales Q/Q- Oper. Margin- RSI (14)69.09 Volatility55.83% 34.29%
OptionableNo Debt/Eq0.00 EPS Q/Q51.90% Profit Margin- Rel Volume526.41 Prev Close3.52
ShortableNo LT Debt/Eq0.00 Earnings- Payout- Avg Volume243.21K Price9.75
Recom3.00 SMA20154.93% SMA50141.83% SMA20036.89% Volume29,791,513 Change176.99%
Sep-23-22 08:51AM
Sep-22-22 04:25PM
Mar-31-22 07:30AM
Feb-16-22 08:20AM
Feb-15-22 10:00PM
07:05AM
Dec-15-21 02:15PM
12:00PM
Dec-12-21 08:00PM
Nov-29-21 08:00AM
Nov-17-21 09:30AM
Nov-12-21 10:40AM
09:20AM
Nov-09-21 09:30PM
Oct-25-21 07:00AM
Aug-26-21 11:04AM
Jun-21-21 08:04AM
Jun-14-21 08:42AM
07:44AM
07:00AM
Apr-26-21 08:09AM
Apr-23-21 11:36PM
09:43AM
08:41AM
Apr-22-21 10:59AM
Apr-21-21 10:34PM
09:38AM
Apr-19-21 10:09PM
06:26AM
Apr-16-21 11:25PM
Apr-14-21 10:34PM
Apr-13-21 11:30PM
03:09PM
02:30PM
09:33AM
06:30AM
Apr-12-21 01:36AM
Jan-11-21 11:32PM
Jan-06-21 09:23AM
Dec-18-20 08:00AM
08:00AM
Dec-17-20 04:27PM
07:00AM
Nov-13-20 05:28AM
Oct-28-20 07:45PM
Oct-23-20 10:00PM
Oct-14-20 08:58PM
10:10AM
Oct-13-20 01:29PM
Oct-12-20 01:35PM
12:45PM
10:47AM
06:30AM
Sep-09-20 08:00AM
Aug-17-20 10:33AM
Aug-14-20 07:30AM
Aug-04-20 12:53PM
Jul-28-20 05:50PM
Jul-22-20 05:50PM
Jul-21-20 08:30AM
Jul-16-20 05:50PM
Jul-09-20 05:50PM
11:30AM
Jul-07-20 11:50AM
Jun-29-20 08:30AM
Jun-25-20 08:44AM
Jun-24-20 12:00PM
11:18AM
Jun-23-20 10:38AM
Jun-18-20 10:12AM
08:50AM
Jun-17-20 11:30AM
Jun-16-20 08:37AM
Jun-15-20 10:00AM
Jun-11-20 08:55AM
08:41AM
Jun-10-20 08:31AM
Jun-09-20 09:41AM
Jun-08-20 08:25AM
Jun-05-20 08:30AM
May-29-20 11:33AM
10:31AM
08:30AM
May-28-20 09:13AM
May-27-20 12:43PM
11:30AM
09:40AM
May-26-20 10:44AM
10:43AM
08:54AM
May-22-20 08:42AM
06:50AM
May-11-20 07:30AM
Apr-27-20 09:48AM
Apr-24-20 11:07AM
Apr-23-20 09:14AM
08:30AM
07:25AM
Apr-16-20 12:00PM
Mar-30-20 07:30AM
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.